神阙经穴给药治疗腹泻型肠易激综合征的疗效观察

张佶玮; 孙建华; 占道伟; 陆为民; 吴晓亮; 张伟; 焦黛妍

神阙经穴给药治疗腹泻型肠易激综合征的疗效观察

1.
南京中医药大学第二临床医学院，江苏南京 210023
2.
南京中医药大学附属医院，江苏南京 210029
3.
江苏省职工康复医院理疗科，江苏南京 211133

计量
- 文章访问数: 934
- HTML全文浏览量: 2
- PDF下载量: 976
- 被引次数: 0
出版历程
- 收稿日期: 2014-05-10
- 修回日期: 2014-06-04
- 刊出日期: 2014-09-10

Clinical Observation on Shenque Point Drug Administration for Shenque Acupoint in Treating Diarrhea-Predominant Irritable Bowel Syndrome

1.
The Second Medical College, Nanjing University of Chinese Medicine, Nanjing, 210023, China
2.
The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, China
3.
Department of Physiotherapy, Jiangsu Province Worker Convalescent Hospital, Nanjing, 211133, China

摘要

摘要: 目的比较神阙经穴给药与西药治疗腹泻型肠易激综合征(IBS-D)脾肾阳虚型的疗效差异。方法采用简单随机数字表法将58例患者随机分为2组。治疗组29例，脱落3例，以神阙经穴给药治疗；对照组29例，脱落2例，以口服得舒特配合金双歧药物治疗。2组治疗4周后进行临床症状疗效对比，评价IBS-D脾肾阳虚证患者的经穴给药疗效。结果经穴给药组总有效率为88.46%，优于对照组的62.96%(P<0.05)；2组临床症状评分差异有统计学意义（P＜0.05）。结论神阙经穴给药能有效治疗脾肾阳虚证腹泻型肠易激综合征，改善临床症状。
- 腹泻型肠易激综合征 /
- 脾肾阳虚证 /
- 经穴给药 /
- 神阙
Abstract: OBJECTIVE To evaluate the differences between point drug delivery's clinical effect on diarrhea-predominant irritable bowel syndrome due to yang insufficiency of both spleen and kidney and the western medicine effect. METHODS 58 patients were randomly divided into two groups by using simple random number table method. 29 cases in treatment group were undertaken drug delivery on Shenque point， of which there were 3 cases defluxion. 29 cases in control group took Decetel and Jinshuangqi of which there were 2 cases defluxion. Clinical curative effect comparison was done after treated for 4 weeks for these two groups and the effect on IBS-D patients belonging to yang insufficiency of both spleen and kidney was evaluated. RESULTS The total effective rate of treatment group was 88.46%， superior to control group of 62.96% (P<0.05). There was statistic significance between two groups (P<0.05). CONCLUSION Point drug delivery with the advantage of improving clinical symptoms is effective on IBS-D patients due to yang insufficiency of both spleen and kidney syndrome.
- IBS-D /
- yang insufficiency of both spleen and kidney syndrome /
- point drug delivery /
- Shenque point.

HTML全文

参考文献(12)

[1]	Saito YA， Schoenfeld P， Locke GR. The epidemiology of irritable bowel syndrome in North America: A systematic review[J]. Am J Gastroenterol， 2002， 97(8): 1910-1915.
[2]	Fukudo S， Kanazawa M， Kano M， et al. Exaggerated motility of the descending colon with repetitive distention of the sigmoid colon in patients with irritable bowel syndrome[J]. J Gastroenterol， 2002， 37(Suppl 14): 145-150.
[3]	中华医学会消化病学分会胃肠动力学组.肠易激综合征诊断和治疗的共识意见[J].中华消化杂志，2008， 28（1）：38-40.
[4]	Chinese Society of Gastroenterology， Gastrointestinal Dynamics Group. Consensus opinion on the diagnosis and treatment of irritable bowel syndrome[J]. Chin J Diges， 2008， 28(1): 38-40.
[5]	中华中医药学会脾胃病分会.肠易激综合征中医诊疗共识意见[J].中华中医药杂志，2010， 25（7）：1062-1065.
[6]	Chinese Society of Spleen and Stomach Disease. Consensus opinion on the TCM diagnosis and treatment of irritable bowel syndrome[J]. Chin J Tradit Chin Med Pharm， 2010， 25(7): 1062-1065.
[7]	中药新药临床研究指导原则(试行)[S]. 北京：中国医药科技出版社， 2002：139-143.
[8]	Clinical research guiding principle of new traditional Chinese medicine (trial implementation)[S]．Beijing: Chinese medical science and technology press， 2002: 139-143.
[9]	张佶玮，孙建华.近3年来神阙穴临床运用规律探析[J].江苏中医药，2012， 44（12）：56-58.
[10]	Zhang JW， Sun JH. Clinical applications rule analysis of Shenque point in recent 3 years[J]. Jiangsu J Tradit Chin Med， 2012， 44(12): 56-58.
[11]	黄帝内经·灵枢[M].北京：人民卫生出版社，2005:51.
[12]	The Yellow Emperor's Inner Classic: The Spiritual Pivot[M]. Beijing: People's medical publishing house， 2005:51.